Furthermore, research has demonstrated that APOA1 expression in small cell lung cancer (SCLC) is higher than in normal lung tissue or non-small cell lung cancer (NSCLC), and that APOA1 expression is significantly lower in patients with recurrent SCLC and those who underwent neoadjuvant chemotherapy prior to surgery (67). Here, APOA1 is linked to small cell lung carcinoma.